Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / UNK||UN / UN|
Administered by: Unknown Purchased by: ??
Symptoms: Amenorrhoea, Death, Fatigue, Mobility decreased, Balance disorder
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data:
CDC 'Split Type': US0095075131812USA003828
Write-up: This spontaneous report was received from an other reporter, who posted an information on independent site in social media and refers to a female (also reported as gender unknown) patient of unknown age. The patient''s medical history, concurrent conditions and concomitant drugs were not reported. On an unknown date, the patient was vaccinated with GARDASIL (dose, lot#, expiry date, route and site of administration were not reported) for prophylaxis. Other suspect therapies included VIOXX tablets (dose, frequency, lot#, expiry date and indication were not reported). On an unknown dates, the patient experienced difficulty to get out of bed, fatigue (sometimes enormous fatigue), problems with balance and an unspecified other symptoms. She also, on an unknown date, lost her period. On an unknown date, the patient died (also reported as "killed"). Cause of death and information about autopsy were not reported. Action taken with suspected therapies was not reported. The outcome of non-fatal events was unknown. The relatedness between the event and suspected drugs was not reported.
Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166